Why is livestock part of the greatest enterprise on Earth?

At GALVmed, we work with partners to makes livestock vaccines, medicines and diagnostics accessible and affordable to smallholder farmers in Africa and South Asia. But why livestock vaccines and health […]

Vaccinating poultry empowers women in rural India #BeBoldForChange

Today, 8th March, the world celebrates International Women’s Day, which is an important catalyst and vehicle for driving greater change for women while moving closer to gender equality. This year’s […]

Tackling the major cause of epilepsy in the developing world

Porcine cysticercosis is a zoonotic disease, which can lead to epilepsy in humans. A new vaccine and dewormer have been registered to counter the disease in pigs thereby stopping the […]

East Coast Fever training curriculum and manual for vaccinators

East Coast Fever (ECF) is a serious, often fatal, disease of cattle that causes major economic losses across 11 countries in eastern, central and southern Africa. Caused by single-celled parasite, […]

From factory to farmer: Creating a sustainable Newcastle Disease vaccine supply chain

For farmers to benefit from animal health products, there has to be a reliable and sustainable supply chain to deliver the products. GALVmed is working with Hester Biosciences Ltd. in […]

Viewpoints @ Brucellosis Vaccine Prize launch: Reaction to prize competition

What’s your reaction to the US $30m Brucellosis prize competition and that it’s funded by the private sector? Gwyn Jones, Chairman of the Responsible Use of Medicines in Agriculture Alliance […]

Viewpoints @ Brucellosis Vaccine Prize launch: Reaction to prize competition

What’s your reaction to the US $30m Brucellosis prize competition and that it’s funded by the private sector? Peter Oostenbach, Associate Director for Global Public Policy Animal Health at Merck […]

Viewpoints @ Brucellosis Vaccine Prize launch: Why a vaccine is important

Why is a vaccine against B. melitensis important? George Tice, Senior Director of Market Access for Europe, Middle East and Africa at Elanco Animal Health responds with his personal view. […]

Viewpoints @ Brucellosis Vaccine Prize launch: Potential impact on untreated diseases

If the Brucellosis Vaccine Prize Competition results in a vaccine, do you think companies could start looking at diseases that remain untreated? Brigitte Boenisch, Head of Regulatory Affairs for Europe, […]

US $30 million prize launched to develop a B. melitensis vaccine

GALVmed and AgResults are delighted to announce the launch of the Brucellosis Vaccine Initiative, a US $30 million prize competition aimed at incentivising animal health companies to develop a vaccine […]